Paolo Durando
- Health top 1%
- Vaccine Coverage and Hesitancy 18
- Epidemiology top 1%
- Influenza Virus Research Studies 44
- Respiratory viral infections research 24
- Pneumonia and Respiratory Infections 21
- Hepatology top 2%
- Hepatitis Viruses Studies and Epidemiology 8
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 9
- Microbiology top 2%
- Bacterial Infections and Vaccines 13
-
- Multiple Sclerosis Research Studies 8
- Co-authors
- Filippo AnsaldiGiancarlo IcardiLaura SticchiGuglielmo DiniRoberto GaspariniAlessandra ToletoneAndrea OrsiNicola Luigi Bragazzi
- Cited by
- HealthEpidemiologyHepatology
- Journals
- The Journal of Immunology (1 paper)PLoS ONE (6 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Paolo Durando
131 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 167
- Health 540
- Epidemiology 1.9k
- Hepatology 380
- Infectious Diseases 800
- Microbiology 218
Countries citing papers authored by Paolo Durando
This map shows the geographic impact of Paolo Durando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Durando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Durando more than expected).
Fields of papers citing papers by Paolo Durando
This network shows the impact of papers produced by Paolo Durando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Durando. The network helps show where Paolo Durando may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paolo Durando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 18 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 9 | |
| 9 | 2020 | 79 | |
| 10 | 2020 | 34 | |
| 11 | 2020 | 14 | |
| 12 | 2019 | 10 | |
| 13 | 2018 | 25 | |
| 14 | 2017 | 5 | |
| 15 | Evidence-based approach for continuous improvement of occupational health. | 2017 | 33 |
| 16 | 2017 | 220 | |
| 17 | 2016 | 130 | |
| 18 | 2012 | 17 | |
| 19 | SARS-CoV, influenza A and syncitial respiratory virus resistance against common disinfectants and ultraviolet irradiation | 2004 | 21 |
| 20 | Sorveglianza epidemiologica e virologica dell'infezione da virus influenzali nella provincia di Lecce: stagione 2000/2001. | 2002 | 1 |
About Paolo Durando
Paolo Durando is a scholar working on Epidemiology, Health and Microbiology, having authored 136 papers that have together received 3.7k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (44 papers), Respiratory viral infections research (24 papers), Pneumonia and Respiratory Infections (21 papers), Vaccine Coverage and Hesitancy (18 papers), Bacterial Infections and Vaccines (13 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Multiple Sclerosis Research Studies (8 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). The work is most often cited by research in Health (540 citations), Epidemiology (1.9k citations) and Hepatology (380 citations). Paolo Durando has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Filippo Ansaldi, Giancarlo Icardi, Laura Sticchi, Guglielmo Dini, Roberto Gasparini, Alessandra Toletone, Andrea Orsi, Nicola Luigi Bragazzi, Nicola Magnavita and Sergio Garbarino. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.